The pen needles market size has grown rapidly in recent years. It will grow from $2.69 billion in 2025 to $2.99 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising global diabetes prevalence, expansion of insulin pen usage, increased availability of self-injection therapies, growth of home healthcare practices, improvements in needle manufacturing technologies.
The pen needles market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing adoption of GLP-1 therapies, rising focus on needle safety regulations, expansion of sustainable disposable medical products, growing demand for painless injection solutions, increasing preference for home-based disease management. Major trends in the forecast period include increasing adoption of ultra-thin pen needles, rising demand for safety pen needle solutions, growing preference for short-length needles, expansion of home-based injection therapies, enhanced focus on patient comfort and compliance.
The rising prevalence of diabetes is expected to drive the growth of the pen needles market in the coming years. Diabetes is a chronic health condition characterized by elevated blood glucose levels resulting from insufficient insulin production or the body’s inability to effectively use insulin. The growing incidence of diabetes is linked to factors such as sedentary lifestyles, poor dietary patterns, genetic susceptibility, urbanization, and aging populations, further intensified by limited healthcare access and increasing obesity rates globally. Pen needles play a vital role in diabetes management by facilitating accurate insulin administration through convenient, minimally invasive injections, supporting improved glycemic control and better patient adherence. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified more than half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total number of people registered with a GP for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This marked a substantial rise compared to 3,065,825 in 2022, reflecting an increase of nearly 20%. Therefore, the growing prevalence of diabetes is driving the expansion of the pen needles market.
Major companies operating in the insulin pen-needle market are concentrating on developing innovative solutions, such as advanced multi-bevel needles, to improve injection comfort and enhance patient compliance. Advanced multi-bevel needles are insulin pen needles engineered with multiple precisely cut bevels at the tip, enabling smoother insertion, reduced pain, and greater comfort for users. For instance, in August 2025, Trividia Health Inc., a US-based diabetes-care company, introduced TRUEplus 5-Bevel Pen Needles in the UK. These pen needles are offered in a range of gauges and lengths (such as 31 G 5 mm, 6 mm, and 8 mm, as well as 32 G 4 mm), feature a silicone coating to minimize friction, are designed for sterile single-use, and include color-coded caps for easy size identification, all aimed at optimizing comfort, safety, and usability. In addition, they are the lowest-priced 5-bevel pen needles available on prescription in the UK, providing a cost-effective yet high-quality alternative to traditional 3-bevel needle designs.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device manufacturer, acquired Ypsomed’s pen-needle and blood-glucose-monitoring (BGM) business. Through this acquisition, MTD expanded its total pen-needle production capacity to more than 2.5 billion units, strengthening its position as a leading global provider of pen needles. Ypsomed Holding AG is a Switzerland-based diabetes care technology company recognized for its range of injection and monitoring solutions.
Major companies operating in the pen needles market are Cardinal Health Inc., Novo Nordisk AS, Becton Dickinson And Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Trividia Health Inc., Medical Technology And Devices S.p.A., Owen Mumford, Dynarex Corporation, UltiMed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., HTL-STREFA S.A., Hindustan Syringes And Medical Devices Ltd., Ypsomed AG, Haselmeier GmbH.
North America was the largest region in the pen needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pen needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pen needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pen needles market by increasing costs of imported stainless steel tubing, polymer hubs, safety mechanisms, and automated needle assembly machinery. Manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressures in large-scale needle production and exports. These tariffs are contributing to higher product prices and margin pressures. However, they are also encouraging regional manufacturing expansion, local sourcing of components, and innovation in cost-optimized and safety-enhanced pen needle designs.
The pen needles market research report is one of a series of new reports that provides pen needles market statistics, including pen needles industry global market size, regional shares, competitors with a pen needles market share, detailed pen needles market segments, market trends and opportunities, and any further data you may need to thrive in the pen needles industry. This pen needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pen needles are small, disposable devices utilized for administering insulin through insulin pens, designed specifically for subcutaneous injection. They are equipped with thin, sharp needles to minimize discomfort and are offered in different lengths and gauges to suit diverse patient requirements and preferences. These needles play a crucial role in diabetes management by enabling convenient and accurate insulin delivery.
The primary categories of pen needles include standard pen needles and safety pen needles. Standard pen needles are medical tools employed for subcutaneous medication injection, mainly for insulin, by individuals managing diabetes. They are available in various lengths such as short-length, medium-length, and long-length pen needles, serving different therapies such as insulin, glucagon-like-peptide-1 (GLP-1), and growth hormone. These needles are accessible in both retail and non-retail environments and are used by various end-users including hospitals, clinics, home healthcare providers, among others.
The pen needles market consists of sales of painless pen needles, adjustable pen needles, reusable pen needles, and fixed-dose pen needles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pen needles market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing adoption of GLP-1 therapies, rising focus on needle safety regulations, expansion of sustainable disposable medical products, growing demand for painless injection solutions, increasing preference for home-based disease management. Major trends in the forecast period include increasing adoption of ultra-thin pen needles, rising demand for safety pen needle solutions, growing preference for short-length needles, expansion of home-based injection therapies, enhanced focus on patient comfort and compliance.
The rising prevalence of diabetes is expected to drive the growth of the pen needles market in the coming years. Diabetes is a chronic health condition characterized by elevated blood glucose levels resulting from insufficient insulin production or the body’s inability to effectively use insulin. The growing incidence of diabetes is linked to factors such as sedentary lifestyles, poor dietary patterns, genetic susceptibility, urbanization, and aging populations, further intensified by limited healthcare access and increasing obesity rates globally. Pen needles play a vital role in diabetes management by facilitating accurate insulin administration through convenient, minimally invasive injections, supporting improved glycemic control and better patient adherence. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified more than half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total number of people registered with a GP for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This marked a substantial rise compared to 3,065,825 in 2022, reflecting an increase of nearly 20%. Therefore, the growing prevalence of diabetes is driving the expansion of the pen needles market.
Major companies operating in the insulin pen-needle market are concentrating on developing innovative solutions, such as advanced multi-bevel needles, to improve injection comfort and enhance patient compliance. Advanced multi-bevel needles are insulin pen needles engineered with multiple precisely cut bevels at the tip, enabling smoother insertion, reduced pain, and greater comfort for users. For instance, in August 2025, Trividia Health Inc., a US-based diabetes-care company, introduced TRUEplus 5-Bevel Pen Needles in the UK. These pen needles are offered in a range of gauges and lengths (such as 31 G 5 mm, 6 mm, and 8 mm, as well as 32 G 4 mm), feature a silicone coating to minimize friction, are designed for sterile single-use, and include color-coded caps for easy size identification, all aimed at optimizing comfort, safety, and usability. In addition, they are the lowest-priced 5-bevel pen needles available on prescription in the UK, providing a cost-effective yet high-quality alternative to traditional 3-bevel needle designs.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device manufacturer, acquired Ypsomed’s pen-needle and blood-glucose-monitoring (BGM) business. Through this acquisition, MTD expanded its total pen-needle production capacity to more than 2.5 billion units, strengthening its position as a leading global provider of pen needles. Ypsomed Holding AG is a Switzerland-based diabetes care technology company recognized for its range of injection and monitoring solutions.
Major companies operating in the pen needles market are Cardinal Health Inc., Novo Nordisk AS, Becton Dickinson And Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Trividia Health Inc., Medical Technology And Devices S.p.A., Owen Mumford, Dynarex Corporation, UltiMed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., HTL-STREFA S.A., Hindustan Syringes And Medical Devices Ltd., Ypsomed AG, Haselmeier GmbH.
North America was the largest region in the pen needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pen needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pen needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pen needles market by increasing costs of imported stainless steel tubing, polymer hubs, safety mechanisms, and automated needle assembly machinery. Manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressures in large-scale needle production and exports. These tariffs are contributing to higher product prices and margin pressures. However, they are also encouraging regional manufacturing expansion, local sourcing of components, and innovation in cost-optimized and safety-enhanced pen needle designs.
The pen needles market research report is one of a series of new reports that provides pen needles market statistics, including pen needles industry global market size, regional shares, competitors with a pen needles market share, detailed pen needles market segments, market trends and opportunities, and any further data you may need to thrive in the pen needles industry. This pen needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pen needles are small, disposable devices utilized for administering insulin through insulin pens, designed specifically for subcutaneous injection. They are equipped with thin, sharp needles to minimize discomfort and are offered in different lengths and gauges to suit diverse patient requirements and preferences. These needles play a crucial role in diabetes management by enabling convenient and accurate insulin delivery.
The primary categories of pen needles include standard pen needles and safety pen needles. Standard pen needles are medical tools employed for subcutaneous medication injection, mainly for insulin, by individuals managing diabetes. They are available in various lengths such as short-length, medium-length, and long-length pen needles, serving different therapies such as insulin, glucagon-like-peptide-1 (GLP-1), and growth hormone. These needles are accessible in both retail and non-retail environments and are used by various end-users including hospitals, clinics, home healthcare providers, among others.
The pen needles market consists of sales of painless pen needles, adjustable pen needles, reusable pen needles, and fixed-dose pen needles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pen Needles Market Characteristics
3. Pen Needles Market Supply Chain Analysis
4. Global Pen Needles Market Trends and Strategies
5. Pen Needles Market Analysis of End Use Industries
7. Global Pen Needles Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pen Needles Total Addressable Market (TAM) Analysis for the Market
9. Pen Needles Market Segmentation
10. Pen Needles Market Regional and Country Analysis
11. Asia-Pacific Pen Needles Market
12. China Pen Needles Market
13. India Pen Needles Market
14. Japan Pen Needles Market
15. Australia Pen Needles Market
16. Indonesia Pen Needles Market
17. South Korea Pen Needles Market
18. Taiwan Pen Needles Market
19. South East Asia Pen Needles Market
20. Western Europe Pen Needles Market
21. UK Pen Needles Market
22. Germany Pen Needles Market
23. France Pen Needles Market
24. Italy Pen Needles Market
25. Spain Pen Needles Market
26. Eastern Europe Pen Needles Market
27. Russia Pen Needles Market
28. North America Pen Needles Market
29. USA Pen Needles Market
30. Canada Pen Needles Market
31. South America Pen Needles Market
32. Brazil Pen Needles Market
33. Middle East Pen Needles Market
34. Africa Pen Needles Market
36. Pen Needles Market Competitive Landscape and Company Profiles
37. Pen Needles Market Other Major and Innovative Companies
40. Pen Needles Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pen Needles Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pen needles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pen needles? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pen needles market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Standard Pen Needles; Safety Pen Needles2) By Needle Length: Short Length Pen Needles; Medium Length Pen Needles; Long Length Pen Needles
3) By Therapy: Insulin; Glucagon-like-Peptide-1 (GLP-1); Growth Hormone
4) By Mode Of Purchase: Retail; Non-Retail
5) By End User: Hospitals And Clinics; Home Healthcare; Other End Users
Subsegments:
1) By Standard Pen Needles: Fixed-Needle Pen Needles; Removable-Needle Pen Needles; Short Pen Needles ( 4mm, 5mm); Long Pen Needles ( 8mm, 12mm)2) By Safety Pen Needles: Automatic Safety Pen Needles; Manual Safety Pen Needles; Retractable Safety Pen Needles; Shielded Safety Pen Needles
Companies Mentioned: Cardinal Health Inc.; Novo Nordisk AS; Becton Dickinson And Company; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Artsana Group; Embecta Corp.; Trividia Health Inc.; Medical Technology And Devices S.p.A.; Owen Mumford; Dynarex Corporation; UltiMed Inc.; Bio-Med HealthCare Products Pvt. Ltd.; Allison Medical Inc.; GlucoRx Ltd.; HTL-STREFA S.A.; Hindustan Syringes And Medical Devices Ltd.; Ypsomed AG; Haselmeier GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pen Needles market report include:- Cardinal Health Inc.
- Novo Nordisk AS
- Becton Dickinson And Company
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Artsana Group
- Embecta Corp.
- Trividia Health Inc.
- Medical Technology And Devices S.p.A.
- Owen Mumford
- Dynarex Corporation
- UltiMed Inc.
- Bio-Med HealthCare Products Pvt. Ltd.
- Allison Medical Inc.
- GlucoRx Ltd.
- HTL-STREFA S.A.
- Hindustan Syringes And Medical Devices Ltd.
- Ypsomed AG
- Haselmeier GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.99 Billion |
| Forecasted Market Value ( USD | $ 4.34 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
